Impaired L-carnitine uptake correlates with higher blood pressure in adult men, and L-carnitine restores endothelial function in aortic rings from spontaneously hypertensive rat (SHR). Thus, endothelial dysfunction in hypertension could result from lower L-carnitine transport in this cell type. L-Carnitine transport is mainly mediated by novel organic cation transporters 1 (Octn1, Na + -independent) and 2 (Octn2, Na + -dependent); however, their kinetic properties and potential consequences in hypertension are unknown. We hypothesize that L-carnitine transport kinetic properties will be altered in aortic endothelium from spontaneously hypertensive rats (SHR). L-Carnitine transport was measured at different extracellular pH (pH o 5.5-8.5) in the absence or presence of sodium in rat aortic endothelial cells (RAECs) from nonhypertensive Wistar-Kyoto (WKY) rats and SHR. Octn1 and Octn2 mRNA relative expression was also determined. Dilation of endothelium-intact or denuded aortic rings in response to calcitonine gene related peptide (CGRP, 0.1-100 nmol/L) was measured (myography) in the absence or presence of L-carnitine. Total L-carnitine transport was lower in cells from SHR compared with WKY rats, an effect due to reduced Na + -dependent (Na transport in cells from SHR. Octn2 mRNA was higher than Octn-1 mRNA expression in cells from both conditions. Dilation of artery rings in response to CGRP was reduced in vessels from SHR compared with WKY rats. CGRP effect was endotheliumdependent and restored by L-carnitine. All together these results suggest that reduced L-carnitine transport (likely via Na + -dependent Octn2) could limit this compound's potential beneficial effects in RAECs from SHR.
Introduction
Essential hypertension is characterized by high blood pressure without an identifiable primary cause [1, 2] . Oral administration of L-carnitine, a natural amino acidic compound, in patients with hypertension resulted in an improvement of arterial blood pressure, thus suggesting a beneficial vascular role for this compound in these subjects [3, 4] . Along with the well-described role of L-carnitine on fatty acid mitochondrial metabolism [5, 6] , L-carnitine also increases the metabolic activity in human vascular endothelium [7, 8] , and improves the bioavailability of nitric oxide (NO) in rat aorta [9] and in fetal lamb pulmonary vasculature [10] . Other studies show that L-carnitine supplementation in healthy subjects improved postprandial flow-mediated dilation after a high-fat meal [11] . Taken together, all these findings suggest that the transport of L-carnitine into the endothelial cells could be an essential, limiting step of its potential beneficial biological effects in hypertension.
The uptake of L-carnitine is mediated by novel organic cation transporters (OCTNs) of which at least three isotypes (rOctn1, rOctn2 and rOctn3) are expressed in rats [12] . Octn1-an Octn3-mediated L-carnitine transport is independent of sodium (Na + ) with apparent Michaelis-Menten (K m ) values in the range of 2-200 mmol/L [13] [14] [15] ] and 3-6 mmol/L [16, 17] , respectively. On the contrary, Octn2-mediated transport is Na + -dependent with apparent K m between 2-20 mmol/L [16, [18] [19] [20] [21] [22] [23] . Studies performed in spontaneously hypertensive rat (SHR) show that Lcarnitine restores endothelial function in preparations of aortic rings [24, 25] , and ameliorates the high-systolic arterial blood pressure exhibited by hypertensive animals [5, 8, 26] . Interestingly, there are no reports addressing the properties of L-carnitine transport in endothelial cells from SHR. Thus, we hypothesize that the activity of OCTNs-mediated membrane transport of Lcarnitine by the aortic endothelium is reduced in these hypertensive animals.
The results of this study show that aorta endothelial cells from SHR exhibit reduced maximal L-carnitine transport capacity compared with cells from non-hypertensive animals. Transport of L-carnitine was saturable and mediated by a larger Na + -independent, Octn1-like compared with a Na + -dependent, Octn2-like transport activity in these cells from SHR. However, similar Na + -dependent and Na + -independent transport components were found in non-hypertensive rats. It is suggested that the observed endothelial dysfunction in SHR could be due to reduced Na + -dependent transport of L-carnitine, which could limit the potential beneficial effects of this compound in the endothelial function in hypertension.
Methods

Ethics statement and animals
This investigation strictly conforms to the principles outlined in the European Union Guidelines on the protection of animals used for scientific purposes (DIRECTIVE 2010/63/EU of the European Parliament and of the Council). Protocols were approved by the Committee on the Ethics of Animal Experiments of the University of Sevilla (Spain). Normotensive male Wistar-Kyoto (WKY) and spontaneously hypertensive rats (SHR) aged 8 weeks were obtained from the French Animal Production Center, JANVIER S.A.S. (Saint Berthevin Cedex, France). Rats were housed at a temperature of 22-24uC in individual cages and freely fed (ad libitum) regular pellet diet (12 mm pellet, Harlan Laboratories, Indianapolis, USA) until they were 10 weeks of age (wa). They were divided into two groups of 15 animals each, i.e., WKY (control) and SHR (hypertensive) animals. Characterization of WKY rats and SHR in terms of the diastolic and systolic blood pressures and body weight was determined at arrival of the animals (8 wa) and at the moment of isolation of aorta endothelial cells (i.e., 10 wa) as reported [26] . Diastolic and systolic blood pressure values were not significantly different (P.0.05) at 8 wa (diastolic = 93 6 3 mmHg, systolic = 123 6 6 mmHg) compared with 10 wa (diastolic = 95 6 2 mmHg, systolic = 124 6 5 mmHg) in WKY rats. However, these parameters were elevated (P,0.01) in SHR at 8 wa (diastolic = 190 6 2 mmHg, systolic = 233 6 2 mmHg) and 10 wa (diastolic = 191 6 2 mmHg, systolic = 231 6 1 mmHg) compared with the corresponding systolic or diastolic values in WKY rats, but were not significantly different (P.0.05) between them in SHR.
Cell culture
Aortas from WKY rats and SHR aged 10 weeks were excised and placed in a petri dish containing phosphate-buffered saline (PBS) solution ((mmol/L) NaCl 130, KCl 2.7, Na 2 HPO 4 0.8, KH 2 PO 4 1.4 (pH 7.4, 4uC)). The tissue was rinsed by changing PBS until free of any visible blood, and the aorta was stripped of adventicia as reported [27] . Rat aorta endothelial cells (RAECs) were isolated by scraping of rat aortic lumen in the presence of medium 199 (M199) (Gibco Life Technologies, Carlsbad, CA, USA) containing 5 mmol/L D-glucose, 10% new born calf serum, 10% fetal calf serum (FCS) (Gibco), 3.2 mmol/L L-glutamine and 100 U/mL penicillin-streptomycin (primary culture medium, PCM) (Gibco), and cultured up to passage 3 (37uC, 5% CO 2 ). Twenty-four hours prior to experiments the incubation medium was replaced by M199 containing 2% sera after two rinses with 200 mL in PBS (37uC). Cells were used in passage 3 for most of the experiments. In addition, in some of transport assays confluent freshly isolated cells (i.e., passage 0) or cells in passages 1 or 2 in culture were also used.
L-Carnitine transport
Total transport of L-carnitine (TTC) was defined as the result of the sum of the Na + -dependent (hereafter referred as TTC Na + dep ) and Na + -independent (hereafter referred as TTC Na + indep ) components plus a nonsaturable, lineal component of transport in the range of L-carnitine used in this study (hereafter referred as mN [Car] , where m corresponds to slopes of lineal phases of TTC at each L-carnitine concentrations [Car]) [28] . The
3 H]carnitine (NEN, Dreieich, FRG), 30 seconds, 37uC) was measured as previously described for other amino acids in primary cultured endothelium [28] . Briefly, TTC assays were performed in a Na 
where v i is initial velocity, V m is mayor velocity at a given time (t) and L-carnitine concentration, and e and k are constants. 
Extracellular pH dependency
To assay the effect of extracellular pH (pH o ) on TSC, TSC Na
3 H]carnitine, 30 seconds, 37uC) the cells were incubated in Na + -containing or Na + -free Krebs adjusted to a final pH o of 5.5, 6.5, 7.5 or 8.5 as described [20] . The pH o in the Na + -containing Krebs solution was adjusted with 1 N HCl or 1 N NaOH, while the Na + -free Krebs solution was adjusted with 1 N HCl or 1 N KOH. The pH o values were monitored with a pHmeter (Oakton Instrument, Vernon Hills, IL, USA) and tracer uptake was terminated as above.
Isolation of total RNA and reverse transcription
Total RNA was isolated using the Trizol reagent (Invitrogen, Carlsbad, CA, USA). RNA quality and integrity were insured by gel visualization and spectrophotometric analysis (OD 260/280 ), and RNA concentration was determined at 260 nm. Aliquots (1 mg) of total RNA were reversed transcribed into cDNA as described [28] .
RT-PCR
Experiments were performed using a Light Cycler 480 Detection System (Roche Diagnostic, Barcelona, Spain) in a reaction mix containing 0.5 mmol/L primers and master mix provided in the brilliant SYBR green qPCR Master Mix (Stratagene, La Jolla, CA, USA). SecureStart Taq DNA polymerase was activated (15 minutes, 95uC), and assays included a 95uC denaturation (15 seconds), annealing (20 seconds) at 54uC, and extension (10 seconds) at 72uC (rOctn1, rOctn2 and GAPDH). Product melting temperature values were 86uC (rOctn1), 86uC (rOctn2) and 85uC (GAPDH). Oligonucleotide primers: rOctn1 (sense) 59-TGATAGCCTTCCTGGGCGATTGG-39, rOctn1 (anti-sense) 59-AAGGAGCCACAGAGAACGCCTAC-39, rOctn2 (sense) 59-AGGAGCCCATCAGCACACCCACG-39, rOctn2 (anti-sense) 59-GACGAAGGACGGACGACAGGTGC-39, GAPDH (sense) 59-GCCAAAAGGGTCATCATCTCCGC-39, GAPDH (anti-sense) 59-GGATGACCTTGCCCACAGCCTTG-39.
The relative mRNA level in each group was estimated from the 2 2DDCT method [29] . Data were analyzed using the Light Cycler 480 SW 1.5 relative quantification (delta-delta-Ct) study software (Roche Diagnostic, Barcelona, Spain) and gene expression levels were normalized to GAPDH and given as relative fold change [30] . The GAPDH mRNA level was not significantly altered (P.0.05, n = 15) in all experimental conditions used in this study (not shown).
Rat aorta reactivity
Ring segments of 2-4 mm in length were dissected from rat aorta in cold (4uC) PBS solution. Vessel rings were mounted in a myograph (610M Multiwire Myograph System, Danish Myo Technology A/S, Denmark) for isometric force measurements in a Krebs physiological solution ((mmol/L): NaCl 118.5, KCl 4.7, NaHCO 3 25, MgSO 4 1.2, KH 2 PO 4 1.2, CaCl 2 2.5, D-glucose 5.5, 300 mmol/L L-arginine, pH 7.4). Artery rings were maintained at 37uC and constantly bubbled with a mixture of 95% O 2 /5% CO 2 . The optimal diameter for each vessel was adjusted through the determination of the maximal active response evoked by 62.5 mmol/L KCl [28] . Isometric force was measured in response to calcitonine gene related peptide (CGRP, 0.1-100 nmol/L, 5 minutes) (Peptides International, Inc., KY, USA) in 32.5 mmol/L KCl preconstricted vessels, in the absence or presence of 20 mmol/ L L-carnitine (30 minutes). In some artery rings, the endothelium was removed by gentle abrasion of the intimal surface. Successful removal of this cell layer was determined by a reduction in the vasodilatation to CGRP. Changes in isometric tension were recorded using the software LabChart (LabChart 7 for Windows, ADInstruments, Australia) coupled to a PowerLab (PowerLab 8/ 30 Data Acquisition System, ADIntruments, Australia). The tissue responses are as a percentage of maximal contraction induced by 62.5 mM KCl.
Statistical analysis
Values are mean 6 SEM, where n indicates the number of different cell cultures (3-4 replicates). Data reported in this study describe a normal standard distribution and comparison between two or more than two groups were performed by means of Student's unpaired t-test and analysis of variance (2-way ANOVA), respectively. If the ANOVA demonstrated a significant interaction between variables, post hoc analyses were performed by the multiple-comparison Bonferroni correction test. The statistical software GraphPad Instat 3.0b and Graphpad Prism 6.0d (GraphPad Software Inc., San Diego, CA, USA) were used for data analysis. P,0.05 was considered statistically significant.
Results
Overall transport of L-carnitine
The TTC for 20 mmol/L L-carnitine was lower (4468%) in RAECs from SHR compared with WKY rats (Fig. 1a) (Fig. 1a) . Cells in passage 0 (Fig. 1b), 1  (Fig. 1c) or 2 (Fig. 1d ) exhibited similar changes in L-carnitine transport compared with cells in passage 3 (Fig. 1a) . The TTC was lineal up to 40 seconds incubation (Fig. 2a) (Fig. 2b) .
L-Carnitine transport kinetics
The TTC was semisaturable in RAECs from either SHR or WKY rats (Fig. 3a,b) (Fig. 3d) . After subtracting the lineal, non-saturable component of transport data (in the range of concentrations used in this study), the saturable transport for each condition was obtained (Fig. 4a,b) . Cells from SHR exhibit reduced V max , but unaltered apparent K m for TSC compared with cells from WKY rats ( Table 1 (Fig. 4c,d) Expression of rOctn1 and rOctn2 mRNA
The relative expression of rOctn2 was higher than rOctn1 mRNA in RAECs from SHR or WKY rats (Fig. 5) . The relative mRNA expression of rOctn2 was largely lower in SHR when compared with WKY; however, no differences were found in mRNA expression of rOctn1 between cells from these animals.
Extracellular pH dependency on saturable L-carnitine transport
Overall transport of L-carnitine was higher at pH o 8.5 compared with transport at pH o 7.4, but it was unaltered by lower pH o values in cells from WKY rats (Fig. 6a) (Table 2) . However, the alkalization required to reduce the overall transport in cells from SHR was higher (,0.22 pH o units of difference) compared with the alkalization required to increase the transport in cells from WKY rats. In addition, the alkalization required to reduce the TSC Na 
Rat aorta reactivity
CGRP caused dilation of preconstricted aortic rings in both group of animals (Fig. 6c) . However, the half-maximal vasodilation (EC 50 ) caused by CGRP was lower in vessels from SHR (EC 50 = 9.560.3 nmol/L) compared with WKY (EC 50 = 1.060.2 nmol/ L) rats. Supplementation with L-carnitine caused a reduction of the EC 50 for CGRP in vessels from SHR (EC 50 = 1.960.3 nmol/ L), but did not alter (P.0.05) this parameter in vessels from WKY rats (EC 50 = 0.960.1 nmol/L). CGRP was ineffective in endothelium-denuded rat aortic rings (Fig. 6d) .
Discussion
We have characterized the kinetics of L-carnitine transport in primary cultures of rat aortic endothelial cells (RAECs) from nonhypertensive WKY rats and contrasted this information with cells from spontaneously hypertensive rats (SHR). Total overall transport of L-carnitine (TTC) was mediated by Na These results are the first demonstration that RAECs from SHR exhibit a phenotype characterized by reduced L-carnitine transport compared with cells from non-hypertensive rats. These results are potentially useful for a better understanding of the membrane transport mechanisms of L-carnitine in RAECs from non-hypertensive WKY rats and SHR. Interestingly, a reduced reactivity to an endothelium dependent vasodilator of the aortic rings from SHR compared with WKY rats was seen, an effect that was improved by supplementation of these vessels in vitro with Lcarnitine. However, vasodilation was absent in endotheliumdenuded aortic ring preparations. It is suggested that a reduced uptake of L-carnitine by the endothelium could counteract the reported beneficial vascular effects of L-carnitine supplementation in subjects with hypertension. 
L-Carnitine transport in normotensive rats
Several reports describe that the natural amino acid L-carnitine could act by improving the high arterial blood pressure in patients with essential hypertension [3, 4] and in animal models of hypertension [5, 26] . These results complement the possibility that in hypertension the membrane transport of this amino acid is reduced, a phenomenon that is supported by studies showing a correlation between increased L-carnitine plasma level and higher blood pressure in adult men [31] . Plasma membrane transport of L-carnitine is mediated by OCTNs in mammalian cells, and the isotypes Octn1, Octn2 and Octn3 have been cloned from rats [12, 32] . Our results show that RAECs exhibit TTC mediated by at least three different components (Na + -dependent ( TTC Na
TTC Na + indep ) and lineal, nonsaturable transport) in the range up to 80 mmol/L L-carnitine. These findings agree with the basic characteristics described for Octn-like transport of this amino acid in other cell types [33] [34] [35] . Since the Eadie-Hofstee representation of the TTC data was not lineal, it is likely that at least two or more transport systems acting in parallel [36, 37] will account for L-carnitine transport in RAECs from non-hypertensive rats. In addition, since the TTC Na + dep and TTC Na + indep components of transport were lineal in the Eadie-Hofstee plot, either a single transport system or two or more transport systems with similar kinetic parameters acting in parallel mediate the Na + -dependent and the Na + -independent L-carnitine transport in this cell type.
Our results also show that cells from WKY rats exhibit a TSC resulting from a pronounced differential contribution of the TSC Na Octn1 is widely expressed in several tissues, including microvascular endothelium from human heart [38] , and mediates Lcarnitine transport via a Na + -independent mechanism [34, 39] with apparent K m values ranging from 2-200 mmol/L [13] [14] [15] .
Since the results of our study show that the apparent K m for the TSC Na + dep and TSC Na + indep components (K m = 21-46 mmol/L) was in the range of values described for this membrane transporter isoform in other cell types [35] , the possibility that Octn1 was responsible of the Na + -independent L-carnitine transport in RAECs from WKY rats is supported. However, Octn2-mediated transport of L-carnitine is described as a Na + -dependent transport mechanism with higher affinity (K m = 2-20 mmol/L) compared to Octn1 [16, [18] [19] [20] [21] [22] . Octn2 is also expressed in other types of endothelial cells, including human heart and brain capillaries endothelium [23, 40] ; therefore Octn2 could also account for the Na + -dependent transport of L-carnitine in RAECs. Interestingly, since the plasma concentration of L-carnitine for WKY rats is reported as 20-36 mmol/L [41] it is likely that the lower affinity transport system Octn1 would play a preferential role compared with Octn2, which is likely to be saturated at physiological Lcarnitine plasma concentrations, in maintaining the extracellular physiological concentrations of this amino acid in these animals.
In the present study, both Octn1 and Octn2 mRNA expression was detected in RAECs from WKY rats. Interestingly, Octn2 mRNA relative expression resulted to be ,31 fold higher compared with Octn1 mRNA in these cells. Since the relative contribution of the TSC Na + dep component to the V max /K m for TSC was ,30%, it is likely that not more than ,10 fold change in Octn2 mRNA expression (estimated from the (Octn2 mRNA/ Octn1 mRNA)/(1/ TSC/Na+-dep F) ratio) could sustain a TSC Na + dep component for the TSC in RAECs. The remaining transport mediated via a TSC Na + indep component (,73%) could represents the contribution of a Na + -independent transport activity derived from Octn1 in this cell type. Interestingly, since the contribution for the Na + -dependent Octn2 transport is reported as ,3 fold higher than the transport detected in the absence of extracellular Na + in other cell types [42] , an equivalent fractional contribution for these components to L-carnitine transport in RAECs from WKY rats could be expected. However, the latter seems unlikely in this cell type since the relative contribution of the TSC Na + dep component to the V max /K m for TSC was ,30% (1/ TSC/Na+-dep F = 0.3) compared with ,73% (1/ TSC/Na+-indep F = 0.73) for the TSC Na + indep component. Thus, contrasting with other cell types [35, 42] , these findings further support the possibility that the Na L-Carnitine transport in RAECs from WKY rats was also dependent on the pH o , a characteristic well described for Octn1 [13, 32] and Octn2 [43] . Our results show that TSC was increased by ,20% by alkalization of the extracellular medium, an effect resulting from a combined increases in the TSC Na ] components regarding the change seen in TSC. Based in these findings, a higher alkalization-dependent increase in the TSC could be reached whether these two transport components were equally altered or whether the TSC Na + indep component was unaltered by this environmental condition. Interestingly, the increase of TSC caused by a change of 0.6 units of pH o in RAECs was ,3.3 fold the increase reported for 150 mmol/L tetraethylammonium (TEA) uptake in response to a similar change in pH o units in HEK293 cells expressing the human OCTN1 form [13] . However, contrasting with these results a larger increase in the pH o value (1 unit of pH o ) reduced overall transport of TEA in these cells [32] . Thus, it is likely that OCTNs-like transport is differentially responsive to the degree of alkalization reached in HEK293 cells. Interestingly, a change in ,0.4 units of pH o has been shown to increase the activity of other membrane transport systems, such as the sodium/proton exchanger isoform 1 in MDCK cells [44] , suggesting that modulation of Octn1/2 by a similar change in the pH o in RAECs agree with what is reported in other cell types. On the other hand, acidification of the extracellular pH o does not alter TSC, a net effect that result from a proportional reduced TSC Na + dep and increased TSC Na + indep transport components. Interestingly the effect of extracellular acidification was similar for both components, suggesting that these components are equally sensitive to acidification in RAECs from WKY rats. Thus, acidification and alkalization of extracellular medium results in a differential modulation of L-carnitine transport in RAECs from nonhypertensive rats.
Effect of spontaneous hypertension on L-carnitine transport
Cells from SHR exhibit a semisaturable TTC unaffected by a lineal, non-saturable component in the range of L-carnitine concentrations used in this study. This data was best fitted to a first-order regression line in an Eadie-Hofstee plot, suggesting that one or more transport systems with apparent K m values in the same range could mediate L-carnitine transport in RAECs from SHR. The apparent K m values for L-carnitine transport by RAECs in SHR were similar to values detected in non-hypertensive rats, and within the range of the plasma L-carnitine concentration reported in SHR (21-41 mmol/L) [41] . Thus, L-carnitine transport via Octn1/2 could contribute to maintain the physiological plasma concentration of this amino acid in SHR. Our results also show that TTC is mainly mediated by a TTC Na + indep (,75%) with a minor contribution of TTC Na + dep (,25%) components. These findings agree with those obtained by contrasting the relative V max /K m for these components with that for TSC. Since Na+-indep/Na+-dep F in WKY rats)/(1/ Na+-indep/Na+-dep F in SHR = 1.03). Thus, reduced overall transport of L-carnitine in RAECs from SHR could be mainly due to reduced expression of the Na + -dependent Octn2 and in a less extend to a reduced expression of the Na + -independent Octn1 membrane transporters. In fact, the Octn2 mRNA expression in cells from SHR is only 2.6 fold compared with Octn1 mRNA expression, a value that is largely minor compared with the 31 fold increase for this mRNA detected in cells from non-hypertensive rats. Thus, a reduced Octn2 expression without alterations in the V max /K m could account for the reduced TSC Na + dep component of L-carnitine transport in RAECs from SHR.
Interestingly, as found in cells from non-hypertensive rats, the relative contribution of the TSC Na + dep component to the V max /K m for TSC was ,30%. Thus, a proportional change by Octn2 expression to (i.e., ,1.48 fold) would sustain the TSC Na + dep component of the saturable transport activity in RAECs from SHR. Interestingly, this value is ,85% lower compared with the potential requested change in Octn2 mRNA expression in cells from non-hypertensive rats. Therefore, SHR is a pathological condition that results in lower request of Octn2 mRNA expression compared with RAECs from non-hypertensive rats. The results also show that L-carnitine transport in RAECs from SHR was dependent on the pH o , supporting the possibility that transport was mediated by Octn1/2 in this cell type. In this case, alkalization of the extracellular medium resulted in reduced TSC, which was due to reduced Na + indep component. This finding is different from RAECs from non-hypertensive rats, suggesting that alkalization could result in a differential down-regulation of L-carnitine transport in RAECs from SHR compared with non-hypertensive rats. However, since the Na + indep component of transport was also reduced in cells from non-hypertensive rats, it is likely that sensitivity of this component to a change in the pH o is similar in cells from SHR and WKY rats.
In conclusion, the kinetic parameters of L-carnitine transport in RAECs from SHR and non-hypertensive WKY rats were characterized. The overall saturable transport was mediated by Na + indep and Na + dep components, with the latter being crucial in the reduced maximal transport capacity detected in cells from SHR. The kinetic parameters, pH o -and Na + -dependency of transport suggest that Octn1 and Octn2 are likely responsible for membrane transport of L-carnitine in endothelial cells from the aorta of SHR and WKY rats. These results are the first characterizing the kinetic parameters for the membrane transport mechanisms of Lcarnitine in rat aortic endothelium from non-hypertensive WKY and spontaneously hypertensive rats. Furthermore, since (a) the reactivity of aortic rings to the endothelium-dependent vasodilator CGRP was reduced in preparations from SHR compared with WKY rats, (b) L-carnitine supplementation in vitro restored CGRP vasodilation to values in vessels from normotensive rats, and (c) CGRP was ineffective in endothelium-denuded rat aortic rings, it is suggested that restoration of a functional endothelium could result from bioavailability of L-carnitine to the aorta endothelium in the spontaneously hypertensive animals. 
